Total Payments
$30,439
2024 Payments
$776.71
Companies
13
Transactions
60
Medicare Patients
531
Medicare Billing
$76,824
Payment Breakdown by Category
Consulting$17,658 (58.0%)
Other$6,845 (22.5%)
Food & Beverage$3,364 (11.1%)
Travel$2,381 (7.8%)
Education$174.94 (0.6%)
Research$17.50 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $17,658 | 6 | 58.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,845 | 2 | 19.2% |
| Food and Beverage | $3,364 | 39 | 11.1% |
| Travel and Lodging | $2,381 | 9 | 7.8% |
| Honoraria | $1,000 | 1 | 3.3% |
| Education | $174.94 | 2 | 0.6% |
| Unspecified | $17.50 | 1 | 0.1% |
Payments by Type
General
$30,422
59 transactions
Research
$17.50
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SERVIER PHARMACEUTICALS LLC | $16,156 | 10 | $0 (2023) |
| BTG International, Inc. | $6,201 | 6 | $0 (2019) |
| Novocure Inc. | $2,075 | 22 | $0 (2024) |
| Agios Pharmaceuticals, Inc. | $1,875 | 1 | $0 (2021) |
| Monteris Medical Corporation | $1,637 | 7 | $0 (2024) |
| INSYS Therapeutics Inc | $997.50 | 1 | $0 (2017) |
| PFIZER INC. | $670.00 | 1 | $0 (2017) |
| Incyte Corporation | $344.55 | 5 | $0 (2024) |
| Genentech USA, Inc. | $229.69 | 2 | $0 (2018) |
| GlaxoSmithKline, LLC. | $108.05 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $776.71 | 8 | Novocure Inc. ($416.63) |
| 2023 | $9,809 | 12 | SERVIER PHARMACEUTICALS LLC ($9,531) |
| 2022 | $5,036 | 7 | SERVIER PHARMACEUTICALS LLC ($4,625) |
| 2021 | $4,003 | 3 | Servier Pharmaceuticals LLC ($2,000) |
| 2020 | $104.15 | 1 | Novocure Inc. ($104.15) |
| 2019 | $6,697 | 11 | BTG International, Inc. ($6,201) |
| 2018 | $1,881 | 9 | Monteris Medical Corporation ($1,585) |
| 2017 | $2,131 | 9 | INSYS Therapeutics Inc ($997.50) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/23/2024 | Monteris Medical Corporation | Neuroblate (Device) | Food and Beverage | In-kind items and services | $33.83 | General |
| Category: Neuroblate | ||||||
| 08/20/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $124.81 | General |
| Category: Oncology | ||||||
| 06/03/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $108.05 | General |
| 05/31/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $167.59 | General |
| Category: Oncology | ||||||
| 05/31/2024 | Incyte Corporation | — | Food and Beverage | Cash or cash equivalent | $43.26 | General |
| 05/15/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Education | In-kind items and services | $99.95 | General |
| Category: Oncology | ||||||
| 05/15/2024 | Incyte Corporation | — | Education | Cash or cash equivalent | $74.99 | General |
| 02/21/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $124.23 | General |
| Category: Oncology | ||||||
| 11/15/2023 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $89.06 | General |
| Category: Oncology | ||||||
| 09/29/2023 | SERVIER PHARMACEUTICALS LLC | — | Consulting Fee | Cash or cash equivalent | $8,160.00 | General |
| 09/29/2023 | SERVIER PHARMACEUTICALS LLC | — | Travel and Lodging | In-kind items and services | $571.30 | General |
| 09/29/2023 | SERVIER PHARMACEUTICALS LLC | — | Travel and Lodging | In-kind items and services | $394.77 | General |
| 09/29/2023 | SERVIER PHARMACEUTICALS LLC | — | Travel and Lodging | Cash or cash equivalent | $201.81 | General |
| 09/29/2023 | SERVIER PHARMACEUTICALS LLC | — | Food and Beverage | In-kind items and services | $120.53 | General |
| 09/29/2023 | SERVIER PHARMACEUTICALS LLC | — | Food and Beverage | In-kind items and services | $68.05 | General |
| 09/29/2023 | SERVIER PHARMACEUTICALS LLC | — | Food and Beverage | Cash or cash equivalent | $14.16 | General |
| 06/05/2023 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $41.49 | General |
| Category: Oncology | ||||||
| 06/04/2023 | Incyte Corporation | ZYNYZ (Drug) | Food and Beverage | Cash or cash equivalent | $37.41 | General |
| Category: Oncology | ||||||
| 05/24/2023 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $88.47 | General |
| Category: Oncology | ||||||
| 02/20/2023 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $22.25 | General |
| Category: Oncology | ||||||
| 12/06/2022 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $87.11 | General |
| Category: Oncology | ||||||
| 11/18/2022 | Novocure Inc. | — | Food and Beverage | Cash or cash equivalent | $27.31 | General |
| 11/17/2022 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $134.47 | General |
| Category: Oncology | ||||||
| 11/16/2022 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $76.83 | General |
| Category: Oncology | ||||||
| 07/27/2022 | SERVIER PHARMACEUTICALS LLC | — | Consulting Fee | Cash or cash equivalent | $2,625.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| FLAG | Monteris Medical Corporation | $17.50 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 119 | 246 | $61,536 | $18,556 |
| 2022 | 4 | 110 | 247 | $54,739 | $15,887 |
| 2021 | 5 | 183 | 365 | $89,052 | $26,421 |
| 2020 | 6 | 119 | 251 | $52,889 | $15,961 |
Total Patients
531
Total Services
1,109
Medicare Billing
$76,824
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 32 | 102 | $21,930 | $6,840 | 31.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 30 | 60 | $17,040 | $5,427 | 31.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 50 | $9,850 | $3,006 | 30.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 17 | $9,350 | $2,241 | 24.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 15 | 17 | $3,366 | $1,041 | 30.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 37 | 101 | $21,715 | $6,933 | 31.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 35 | 108 | $21,276 | $5,912 | 27.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $6,600 | $1,615 | 24.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 26 | 26 | $5,148 | $1,428 | 27.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 53 | 152 | $29,944 | $8,479 | 28.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 38 | 104 | $22,360 | $7,552 | 33.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 33 | 36 | $19,800 | $5,602 | 28.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 41 | 44 | $8,712 | $2,460 | 28.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 18 | 29 | $8,236 | $2,328 | 28.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 42 | 139 | $27,805 | $7,844 | 28.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 22 | 53 | $9,115 | $2,941 | 32.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 14 | 15 | $6,710 | $2,358 | 35.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 13 | 14 | $4,636 | $1,496 | 32.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 15 | 16 | $2,761 | $840.79 | 30.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 13 | 14 | $1,862 | $482.76 | 25.9% |
About Dr. Glenn Lesser, MD
Dr. Glenn Lesser, MD is a Medical Oncology healthcare provider based in Winston Salem, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1205810660.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Glenn Lesser, MD has received a total of $30,439 in payments from pharmaceutical and medical device companies, with $776.71 received in 2024. These payments were reported across 60 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($17,658).
As a Medicare-enrolled provider, Lesser has provided services to 531 Medicare beneficiaries, totaling 1,109 services with total Medicare billing of $76,824. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical Oncology
- Location Winston Salem, NC
- Active Since 11/30/2005
- Last Updated 05/13/2008
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1205810660
Products in Payments
- VORAXAZE (Drug) $6,201
- Neuroblate (Device) $1,619
- Optune (Device) $1,401
- SYNDROS (Drug) $997.50
- Oncology (Device) $646.77
- Avastin (Biological) $115.29
- DARZALEX (Biological) $99.95
- ZYNYZ (Drug) $37.41
- Rebif (Biological) $28.83
- NeuroBlate (Drug) $17.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Winston Salem
Dr. Steven Sorscher, Md, MD
Medical Oncology — Payments: $595,141
Medical Oncology $595,141
Istvan Molnar, Md, MD
Medical Oncology — Payments: $83,943
Medical Oncology $83,943
Bayard Powell, Md, MD
Medical Oncology — Payments: $60,450
Medical Oncology $60,450
Erin Jepsen, M.d, M.D
Medical Oncology — Payments: $18,410
Medical Oncology $18,410
Susan Melin, Md, MD
Medical Oncology — Payments: $2,126
Medical Oncology $2,126
Julia Lawrence, Do, DO
Medical Oncology — Payments: $1,371
Medical Oncology $1,371